At a glance
- Originator Nonindustrial source
- Class Antihistamines; Nootropics
- Mechanism of Action Histamine H3 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cognition disorders
Most Recent Events
- 25 Aug 1998 No-Development-Reported for Cognition disorders in France (Unknown route)
- 25 Aug 1998 No-Development-Reported for Cognition disorders in United Kingdom (Unknown route)
- 23 Jul 1996 New profile